Impact of race/ethnicity on molecular pathways in human cancer

Understanding the molecular circuitry of the cancer cell is within the grasp of the basic scientist; however, harnessing this knowledge to predict cancer risk requires integration of molecular and population sciences. But, what role, if any, does race/ethnicity have in cancer research and, more specifically, in the nature of genetic and epigenetic alterations that programme the malignant behaviour of the cancer cell?

[1]  E. Yu,et al.  p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. , 2003, Cancer letters.

[2]  Hua Tang,et al.  Categorization of humans in biomedical research: genes, race and disease , 2002, Genome Biology.

[3]  R. Schwartz.  Racial profiling in medical research. , 2001, The New England journal of medicine.

[4]  N. Heerema,et al.  Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. , 2002, Blood.

[5]  大澤 俊也.  Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma , 2003 .

[6]  T. Motoyama,et al.  Frequent Epigenetic Silencing of the p16 Gene in Non‐small Cell Lung Cancers of Tobacco Smokers , 2002, Japanese journal of cancer research : Gann.

[7]  S. Peiper,et al.  From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. , 1997, Blood.

[8]  C. Tournamille,et al.  Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.

[9]  H. Aburatani,et al.  Global and non‐random CpG‐island methylation in gastric carcinoma associated with Epstein‐Barr virus , 2003, Cancer science.

[10]  J. Kwong,et al.  Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  R. Kittles,et al.  High incidence of microsatellite instability in colorectal cancer from African Americans. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. , 2003, Journal of the National Cancer Institute.

[13]  S. Mittnacht,et al.  p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma , 2002, Oncogene.

[14]  M. Gulley,et al.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation , 2002, Journal of clinical pathology.

[15]  K. Ness,et al.  Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. , 2003, JAMA.

[16]  J. Minna,et al.  Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer , 2003, International journal of cancer.

[17]  E. Friedman,et al.  p53 and WAF1 polymorphisms in Jewish‐Israeli women with epithelial ovarian cancer and its association with BRCA mutations , 2000, BJOG : an international journal of obstetrics and gynaecology.

[18]  S. Selvin,et al.  Black-white differences in stage-specific cancer survival: analysis of seven selected sites. , 1991, American journal of epidemiology.

[19]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[20]  B. Gusterson,et al.  Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. , 2002, Cancer research.

[21]  V. Pinn,et al.  Histopathology of breast cancer among African‐American women , 2003, Cancer.

[22]  S. Sommer,et al.  p53 As a mutagen test in breast cancer , 2002, Environmental and molecular mutagenesis.

[23]  H M Rosenberg,et al.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.

[24]  J. Mountain,et al.  The meanings of "race" in the new genomics: implications for health disparities research. , 2001, Yale journal of health policy, law, and ethics.

[25]  G. Dahlberg,et al.  Genetics of human populations. , 1948, Advances in genetics.

[26]  E. Mark,et al.  p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. , 2001, Cancer research.

[27]  I. Barshack,et al.  Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in Israel. , 2000, European journal of cancer.

[28]  D. West,et al.  Socioeconomic status and breast carcinoma survival in four racial/ethnic groups , 2003, Cancer.

[29]  D. Heimburger,et al.  Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States) , 2003, Cancer Causes & Control.

[30]  P. Hartge,et al.  The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews , 1998, Nature Genetics.

[31]  J. Downing,et al.  Results of therapy for acute lymphoblastic leukemia in black and white children. , 2003, JAMA.

[32]  N. Risch,et al.  The importance of race and ethnic background in biomedical research and clinical practice. , 2003, The New England journal of medicine.

[33]  K. Aldape,et al.  Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  K. Kelsey,et al.  Patterns of gene promoter methylation in squamous cell cancer of the head and neck , 2002, Oncogene.

[35]  S. O’Brien,et al.  Markers for mapping by admixture linkage disequilibrium in African American and Hispanic populations. , 2001, American journal of human genetics.

[36]  C. Harris,et al.  The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.

[37]  F. Collins,et al.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals , 1995, Nature Genetics.

[38]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[39]  J. Kelsey,et al.  Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. , 2000, Epidemiologic reviews.

[40]  A. Kraus,et al.  Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  David B. Goldstein,et al.  Population genetic structure of variable drug response , 2001, Nature Genetics.

[42]  A. Sloan,et al.  Racial differences in survival after diagnosis with primary malignant brain tumor , 2003, Cancer.

[43]  L. Aaltonen,et al.  The I1307K polymorphism of the APC gene in colorectal cancer. , 1999, Gastroenterology.

[44]  D. B. Berman,et al.  A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. , 1996, Cancer research.

[45]  M. Buendia,et al.  Genetic Alterations and Oncogenic Pathways in Hepatocellular Carcinoma , 2002, Annals of the New York Academy of Sciences.

[46]  L. Wasserman,et al.  Genomic control, a new approach to genetic-based association studies. , 2001, Theoretical population biology.

[47]  S. Thorgeirsson,et al.  Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China , 2002, Hepatology.

[48]  J. Stephens,et al.  Haplotype Variation and Linkage Disequilibrium in 313 Human Genes , 2001, Science.

[49]  N. Muñoz,et al.  Risk Factors for HPV DNA Detection in Middle‐Aged Women , 1996, Sexually transmitted diseases.

[50]  K. Aldape,et al.  Ethnicity delineates different genetic pathways in malignant glioma. , 2001, Cancer research.

[51]  D. Fishman,et al.  BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. , 2000, American journal of human genetics.

[52]  J. Mikovits,et al.  Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation , 2001, Journal of Virology.

[53]  T Paschke,et al.  Analysis of different versions of the IARC p53 database with respect to G-->T transversion mutation frequencies and mutation hotspots in lung cancer of smokers and non-smokers. , 2000, Mutagenesis.

[54]  L. Norton,et al.  BRCA-associated breast cancer: absence of a characteristic immunophenotype. , 1998, Cancer research.

[55]  F. Sarkar,et al.  Clinicopathologic Analysis of Pancreatic Adenocarcinoma in African Americans and Caucasians , 2003, Pancreas.

[56]  M. Feldman,et al.  The application of molecular genetic approaches to the study of human evolution , 2003, Nature Genetics.

[57]  M. King,et al.  Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. , 1998, American journal of human genetics.

[58]  C. Carter,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.

[59]  M. Oren,et al.  Regulation of p53: intricate loops and delicate balances. , 2002, Biochemical pharmacology.

[60]  Melissa Bondy,et al.  Epidemiology of primary brain tumors: current concepts and review of the literature. , 2002, Neuro-oncology.

[61]  Y. Iwadate,et al.  Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients. , 1999, International journal of oncology.

[62]  M. Ratain,et al.  Pharmacogenomics: road to anticancer therapeutics nirvana? , 2003, Oncogene.

[63]  M. King,et al.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. , 1996, American journal of human genetics.

[64]  H. Anton-Culver,et al.  Survival differences in breast cancer among racial/ethnic groups: a population-based study. , 1999, Cancer detection and prevention.

[65]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[66]  M. Leshno,et al.  The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[67]  P Rozen,et al.  Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. , 1999, Gastroenterology.

[68]  S. Gallinger,et al.  Somatic instability of the APC I1307K allele in colorectal neoplasia. , 1998, Cancer research.

[69]  R. Royak-Schaler,et al.  Tumor biology and prognosis in black breast cancer patients: a review. , 2001, Cancer detection and prevention.

[70]  Moshe Oren,et al.  Regulation of p53: intricate loops and delicate balances. , 2002, Biochemical pharmacology.

[71]  M. Fukayama,et al.  Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. , 2001, Current topics in microbiology and immunology.

[72]  R. Kittles,et al.  Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. , 2001, American journal of physical anthropology.

[73]  W. Carroll.  Race and outcome in childhood acute lymphoblastic leukemia. , 2003, JAMA.

[74]  Acknowledgements , 1992, Experimental Gerontology.

[75]  Diane D. Liu,et al.  Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. , 2002, Cancer research.

[76]  K. Malone,et al.  Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[77]  D. Wright,et al.  Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis , 1998, Leukemia.

[78]  Tobacco use among U.S. racial/ethnic minority groups--African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. A Report of the Surgeon General. Executive summary. , 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[79]  D. Sidransky,et al.  Role of the p16 tumor suppressor gene in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  John K. Wiencke,et al.  p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer , 2001 .

[81]  Alfred A. Boyd,et al.  Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.

[82]  E. Fontham,et al.  Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[83]  J. Groopman,et al.  Translational strategies for cancer prevention in liver , 2003, Nature Reviews Cancer.

[84]  A. Blum,et al.  Tobacco Use Among U.S. Racial/Ethnic Minority Groups-African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General , 1998 .

[85]  P. Hartge,et al.  Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.

[86]  D. Fang,et al.  Effect of HCV infection on expression of several cancer-associated gene products in HCC. , 1999, World journal of gastroenterology.

[87]  H. Ostrer,et al.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC , 1997, Nature Genetics.

[88]  M. Fukayama,et al.  Reduced Expression and Promoter Methylation p16 Gene in Epstein‐Barr Virus‐associated Gastric Carcinoma , 2002, Japanese journal of cancer research : Gann.